Stocktoria
Structure Therapeutics Inc. GPCR
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2023-02-03
Structure Therapeutics Inc. statistics & valuation
Market cap$3.4B
P / B2.3×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Return on assets | -8.9% | -13.6% | -18.6% | -52.5% |
| Return on equity | -9.3% | -14.2% | -19.8% | 44.6% |
| Current ratio | 24.81 | 24.74 | 19.14 | 7.16 |
Source: SEC EDGAR filings · CIK 0001888886 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.